AIRNA
AiRNA
AIRNA is an AI-driven mRNA sequence-design platform developed by METiS Pharmaceuticals, a Chinese AI-enabled drug-delivery company, as part of its broader NanoForge technology stack that also includes AiTEM and AiLNP . It should not be confused with the U.S.-based biotech AIRNA, which was founded with ARCH Venture Partners' support and focuses on RNA-editing therapeutics . elsewhere's corpus does not contain standalone coverage of the AIRNA platform as an independent subject.
AI-generated — may contain errors, please verify.
Coverage
5Y News | Congratulations to METiS Pharmaceuticals on its Hong Kong Stock Exchange listing!
METiS Pharmaceuticals, the world's first publicly listed AI-driven drug delivery company, goes public, ushering in a new era for biopharmaceuticals.
Heart Capital Congratulates METiS Pharmaceuticals on Successful Listing on the Main Board of the Hong Kong Stock Exchange | Heart Star PORTFOLIO
The world's first publicly listed AI drug delivery company.
AIRNA Closes $90 Million Series A to Advance Novel RNA-Editing Therapeutics
Accelerate the advancement of best-in-class drug candidates into clinical trials.
5Y News | 5Y Capital Portfolio Company METiS Pharmaceuticals Closes $100 Million Series C Round
Focused on "AI-powered drug delivery."
